Keyword      Search in       

Contact
Imprint
Privacy Policy
Site Map

RSS Feed News. Your shopping cart.

Google gadget.

GMP News
05/06/2012
 

New USP Chapter <1083> on Good Distribution Practices

  
A new general USP Chapter <1083> Good Distribution Practices - Supply Chain Integrity has been presented in the new issue of the USP Pharmacopeial Forum (volume 38, edition 2).

The main issue of the new chapter focuses on counterfeited medicines. Here are the topics which are dealt with in detail:

  • Legal definition of counterfeit medicines (laid down in an EU Directive for Europe, in FDCA, 21 USC 321 § 201 for the USA, inexistent in some countries),
  • Types of counterfeit medicines,
  • Medical consequences of counterfeit medicines (heparin, diethylene glycol),
  • Distribution (e.g. also via internet).

A paragraph entitled "Best Practices to combat Counterfeit Drugs and Medical Devices" presents a range of measures and possibilities to combat counterfeit medicines:

  • Packaging technologies (secured packaging, authentication and serialisation technologies, etc.),
  • Establishment of Pedigrees / e-Pedigress,
  • Use of 2D bar codes (ECC 200) or RFID tags,
  • Precise security guidance regarding all repackaging activities - repackagers should perform equivalent protection measures with the original ones and ensure the total destruction of the removed packaging,
  • Diversion and theft (implementation of "Good Trucking Security Practices" to check and ensure the goods during transportation through the supply chain).

Pharmaceutical manufacturers should establish a global and dedicated team to oversee product security. Furthermore, measures and steps are recommended when a counterfeit product or suspected counterfeit product is detected in the supply chain. The new chapter will be added to USP 36.

To view the document, you need to register for the Pharmacopeial Forum.

At the Anti-Counterfeit Conference - Strategies against Falsified / Counterfeit Medicines - organised by the University of Würzburg on 7 - 8 May 2012, Dr Leigh Verbois from the Office of Drug Security, Integrity, and Recalls, CDER, FDA, USA will present the new FDA Supply Chain Integrity Initiatives (via Video Conference).

Author:
Dr Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)

Conference Recommendations

Related GMP News
24/04/2013EudraGMP Database now also comprises GDP Information
12/03/2013Final Good Distribution Practices (GDP) Guideline published by EU Commission
06/03/2013China Publishes New Good Distribution Practices
20/02/2013Good Distribution Practices for APIs - EU Commission Publishes Draft Guideline
24/10/2012Draft Guideline on Good Distribution Practices for Biological Products published by CDSCO